Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBILB.L Regulatory News (BILB)

  • There is currently no data for BILB

Director/PDMR Shareholding

11 Mar 2020 15:41

RNS Number : 8216F
Bilby PLC
11 March 2020
 

11 March 2020

Bilby plc

("Bilby", or the "Company")

Director/PDMR Shareholding

The Company was notified on 10 March 2020 that Mr. David Bullen, CEO of Bilby, transferred for nil consideration 682,241 ordinary shares of 10 pence each in the capital of the Company ("Ordinary Shares") at a price of 15 pence per Ordinary Share to his SIPP on 10 March 2020 (the "Transfer"). Save for the sale of 298 Ordinary Shares to cover dealing costs in respect of the Transfer, there is no further change to Mr. Bullen's beneficial ownership of Ordinary Shares in the Company.

Following the Transfer, Mr. Bullen and his persons closely associated are interested in 1,136,487 Ordinary Shares, representing 1.94 per cent of the issued share capital of the Company.

- ends -

 

Enquiries

 

Bilby plc

 

Sangita Shah, Chairman

David Bullen, Chief Executive Officer

 

+44 (0)20 7796 4133

(via Hudson Sandler)

 

 

Canaccord Genuity Ltd (Nominated Adviser and Sole Broker)

+44 (0)20 7523 8000

Corporate Broking:

Bobbie Hilliam

Andrew Potts

Georgina McCooke

Sales:

Jonathan Barr

 

 

 

 

Hudson Sandler (Financial PR)

+44 (0)20 7796 4133

Charlie Jack

Bertie Berger

 

 

 

Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014

1

Details of the person discharging managerial responsibilities/person closely associated

a.

Name

David Bullen

2

Reason for notification

 

a.

Position/Status

CEO and PDMR

b.

Initial notification/ Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Bilby Plc

b.

LEI

213800JDWVCVYWS87928

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the financial instrument, type of instrumentIdentification Code

Ordinary Shares of 10 pence each 

GB00BV9GHQ09 

b.

Nature of the transaction

Sale of Ordinary Shares for nil consideration

c.

Price(s) and volume(s)

Price(s)

Volume(s)

-

 682,241

 

d.

Aggregated information

- Aggregated Volume

- Price

Not applicable - single transaction

 

 

e.

Date of the transaction

10 March 2020

f.

Place of the transaction

London Stock Exchange

Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014

1

Details of the person discharging managerial responsibilities/person closely associated

a.

Name

David Bullen

2

Reason for notification

 

a.

Position/Status

CEO and PDMR

b.

Initial notification/ Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Bilby Plc

b.

LEI

213800JDWVCVYWS87928

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the financial instrument, type of instrumentIdentification Code

Ordinary Shares of 10 pence each 

GB00BV9GHQ09 

b.

Nature of the transaction

Sale of Ordinary Shares

c.

Price(s) and volume(s)

Price(s)

Volume(s)

15 pence

298

 

d.

Aggregated information

- Aggregated Volume

- Price

Not applicable - single transaction

 

 

e.

Date of the transaction

10 March 2020

f.

Place of the transaction

London Stock Exchange

 

Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014

1

Details of the person discharging managerial responsibilities/person closely associated

a.

Name

David Bullen

2

Reason for notification

 

a.

Position/Status

CEO and PDMR

b.

Initial notification/ Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Bilby Plc

b.

LEI

213800JDWVCVYWS87928

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the financial instrument, type of instrumentIdentification Code

Ordinary Shares of 10 pence each 

GB00BV9GHQ09 

b.

Nature of the transaction

Purchase of Ordinary Shares for nil consideration

c.

Price(s) and volume(s)

Price(s)

Volume(s)

 -

 682,241

 

d.

Aggregated information

- Aggregated Volume

- Price

Not applicable - single transaction

 

 

e.

Date of the transaction

10 March 2020

f.

Place of the transaction

London Stock Exchange

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHEFLFFBXLLBBL
Date   Source Headline
24th Sep 20197:00 amRNSUpdate re Director
19th Sep 20197:00 amRNSFull Year Results
1st Aug 20197:00 amRNSTrading update
11th Jul 20194:44 pmRNSChange of Registered Office/Co-Sec
5th Apr 20197:00 amRNSDirectorate Change
18th Mar 20197:00 amRNSAppointment of COO
5th Mar 20194:41 pmRNSSecond Price Monitoring Extn
5th Mar 20194:35 pmRNSPrice Monitoring Extension
5th Mar 20197:00 amRNSTrading Update
21st Jan 20191:08 pmRNSPayment of Dividend
12th Dec 201810:38 amRNSDirector/PDMR Shareholding
11th Dec 20187:00 amRNSInterim Results
29th Nov 20187:00 amRNSAcquisition of R. Dunham
7th Nov 20187:00 amRNSAppointment of Finance Director and Nomad
11th Sep 20185:52 pmRNSResult of AGM & Payment of Final Dividend
7th Sep 201811:34 amRNSHolding(s) in Company
6th Sep 20183:58 pmRNSReplacement: Holding(s) in Company
5th Sep 201811:09 amRNSHolding(s) in Company
4th Sep 20184:31 pmRNSHolding(s) in Company
4th Sep 20187:00 amRNSSale of Founder's Shares and Board Changes
6th Aug 201812:57 pmRNSReplacement: Annual Report and Notice of AGM
2nd Aug 20182:02 pmRNSAnnual Report and Notice of AGM
16th Jul 20181:25 pmRNSUnaudited Preliminary Results
10th May 20188:18 amRNSHolding(s) in Company
23rd Apr 20187:00 amRNSHolding(s) in Company
5th Apr 201811:23 amRNSHolding(s) in Company
21st Feb 20187:00 amRNSTrading update
31st Jan 201811:31 amRNSNotice of General Meeting
24th Jan 20182:30 pmRNSPayment of Interim Dividend
17th Jan 20187:00 amRNSStatement re: CarillionAmey Limited
12th Jan 20182:08 pmRNSShareholder Circular and Notice of General Meeting
21st Dec 20173:39 pmRNSPayment of Historic Dividends and General Meeting
21st Nov 20177:00 amRNSInterim Results
27th Sep 20173:29 pmRNSSpokemead Maintenance Limited Consideration
15th Sep 201710:01 amRNSHolding(s) in Company
4th Aug 201710:29 amRNSResult of AGM
20th Jul 20174:55 pmRNSHolding(s) in Company
20th Jul 20172:49 pmRNSHolding(s) in Company
14th Jul 20177:00 amRNSLoan Note, Grant of Options and Issue of Shares
13th Jul 20177:00 amRNSAnnual Report, Notice of AGM & DCB Consideration
26th Jun 20177:00 amRNSPreliminary Results
15th May 20177:00 amRNSTrading Update
12th Apr 20177:00 amRNSPre-close Trading Update and Change of Adviser
21st Dec 20164:30 pmRNSHolding(s) in Company
20th Dec 20169:43 amRNSDividend Timetable
16th Dec 20167:01 amRNSDirectorate Changes
16th Dec 20167:00 amRNSHalf-year Report
8th Dec 201611:05 amRNSSecond Price Monitoring Extn
8th Dec 201611:00 amRNSPrice Monitoring Extension
7th Dec 20162:25 pmRNSRestatement of Prior Year Financial Statements

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.